Teva Branded Pharmaceutical Products R&d, Inc.

This study tested a drug called fremanezumab to prevent migraines in 365 Chinese adults. Participants received either monthly or quarterly injections, or a placebo. The goal was to see if the drug could reduce the number of migraine days per month. The drug is designed to block a…

This study tested an investigational drug called TEV-48574 in 290 adults with moderate to severe ulcerative colitis or Crohn's disease. The goal was to see if the drug could reduce inflammation and bring about remission after 14 weeks of treatment. Participants received one of tw…

This study tested a drug called fremanezumab to see if it can prevent chronic migraines in children aged 6 to 17. Chronic migraine means having 15 or more headache days per month. The study compared the drug to a placebo (a shot with no medicine) and tracked how many migraine day…